Dermatologic AgentsSkin DiseasesDermatologyAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantTreatment OutcomeCyclophosphamideAntineoplastic AgentsCisplatinDoxorubicinSkin Diseases, ViralCombined Modality TherapyEtoposideDermatomycosesDrug Administration ScheduleDisease-Free SurvivalSkin Diseases, InfectiousExanthemaSurvival AnalysisVincristineAcne VulgarisMethotrexateBleomycinVinblastineSurvival RateIfosfamidePruritusTaxoidsSkin Diseases, VascularPaclitaxelBreast NeoplasmsDrug EruptionsNeoplasm StagingLung NeoplasmsEl Nino-Southern OscillationDermatitis, SeborrheicPrognosisAnthracyclinesDeoxycytidineSalvage TherapyCarboplatinNeoadjuvant TherapyLymphoma, Non-HodgkinOrganoplatinum CompoundsFluorouracilSkin Diseases, ParasiticLichen PlanusErythemaNeutropeniaSkin CareNeoplasm Recurrence, LocalCytarabineAlopeciaNeoplasmsPsychoneuroimmunologyHodgkin DiseaseNauseaInfusions, IntravenousAntimetabolites, AntineoplasticNeoplasm MetastasisLomustineVomitingDrug Resistance, NeoplasmOnychomycosisPrednisoneVulvar DiseasesFollow-Up StudiesAntineoplastic Agents, AlkylatingHair DiseasesSkin AgingAntineoplastic Agents, PhytogenicCarcinoma, Non-Small-Cell LungGranulocyte Colony-Stimulating FactorCamptothecinProspective StudiesSkin NeoplasmsSkin Diseases, BacterialTransplantation, AutologousDacarbazineEpirubicinPyoderma GangrenosumDose-Response Relationship, DrugHand DermatosesMitoxantroneSkinTesticular NeoplasmsProcarbazineIchthyosisColorectal NeoplasmsRetrospective StudiesOvarian NeoplasmsLeucovorinTime FactorsClinical Trials as TopicLeukopeniaNeoplasms, Germ Cell and EmbryonalAntibodies, Monoclonal, HumanizedRemission InductionRadiotherapy, AdjuvantAntiemetics